Soiken to Establish New Subsidiary for Virus and Fatigue Biomarker Research.Tokyo, Japan, Dec 6, 2005 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Soiken announced on December 5 that it has decided to establish a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. in collaboration with Jikei University Professor Kazuhiro Kondo on December 8. To be capitalized at 50 million yen ($415,000), Virus Ikagaku Kenkyusho (provisional name) will proceed with research on viruses such as human herpesvirus herpesvirus, any of the family (Herpesviridae) of common DNA-containing viruses, many of which are associated with human disease. See cytomegalovirus; Epstein-Barr virus; herpes simplex; herpes zoster. with a view to applying them as a biomarker for assessing fatigue. In addition, the new subsidiary will enter into a joint research agreement with Japan Tobacco. In the two-year research project, the two companies will strive to develop a method of assessing the degree of fatigue and quantifying latent viruses Latent virus A nonactive virus which is in a dormant state within a cell. Herpes virus is latent in cells of the nervous system. Mentioned in: Genital Herpes by leveraging their respective expertise. Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion